nodes	percent_of_prediction	percent_of_DWPC	metapath
Deferasirox—CYP3A4—prostate cancer	0.4	1	CbGaD
Deferasirox—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.117	0.207	CbGbCtD
Deferasirox—CYP3A4—Bicalutamide—prostate cancer	0.0614	0.109	CbGbCtD
Deferasirox—CYP3A4—Estramustine—prostate cancer	0.0571	0.101	CbGbCtD
Deferasirox—CYP3A4—Abiraterone—prostate cancer	0.0509	0.09	CbGbCtD
Deferasirox—CYP3A4—Flutamide—prostate cancer	0.0509	0.09	CbGbCtD
Deferasirox—CYP3A4—Cabazitaxel—prostate cancer	0.0377	0.0666	CbGbCtD
Deferasirox—CYP3A4—Estrone—prostate cancer	0.0368	0.0651	CbGbCtD
Deferasirox—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0328	0.058	CbGbCtD
Deferasirox—CYP3A4—Conjugated Estrogens—prostate cancer	0.0241	0.0426	CbGbCtD
Deferasirox—CYP3A4—Mitoxantrone—prostate cancer	0.0219	0.0387	CbGbCtD
Deferasirox—CYP3A4—Estradiol—prostate cancer	0.0211	0.0374	CbGbCtD
Deferasirox—CYP3A4—Prednisone—prostate cancer	0.0182	0.0321	CbGbCtD
Deferasirox—CYP3A4—Etoposide—prostate cancer	0.0138	0.0244	CbGbCtD
Deferasirox—CYP3A4—Docetaxel—prostate cancer	0.0126	0.0223	CbGbCtD
Deferasirox—CYP3A4—Doxorubicin—prostate cancer	0.00942	0.0166	CbGbCtD
Deferasirox—Telmisartan—CYP2C19—prostate cancer	0.000619	0.321	CrCbGaD
Deferasirox—Conivaptan—CYP3A4—prostate cancer	0.000604	0.313	CrCbGaD
Deferasirox—Magnesium salicylate—PTGS2—prostate cancer	0.000381	0.198	CrCbGaD
Deferasirox—CYP3A4—Farnesoid X Receptor  Pathway—SULT2A1—prostate cancer	0.000327	0.0101	CbGpPWpGaD
Deferasirox—Salsalate—PTGS2—prostate cancer	0.000324	0.168	CrCbGaD
Deferasirox—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—prostate cancer	0.000322	0.00995	CbGpPWpGaD
Deferasirox—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—prostate cancer	0.000312	0.00963	CbGpPWpGaD
Deferasirox—CYP3A4—Tamoxifen metabolism—SULT2A1—prostate cancer	0.000301	0.00931	CbGpPWpGaD
Deferasirox—CYP3A4—Constitutive Androstane Receptor Pathway—CYP3A5—prostate cancer	0.000294	0.00908	CbGpPWpGaD
Deferasirox—CYP3A4—Xenobiotics—CYP2C19—prostate cancer	0.000279	0.00862	CbGpPWpGaD
Deferasirox—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—prostate cancer	0.000274	0.00846	CbGpPWpGaD
Deferasirox—CYP3A4—Xenobiotics—CYP2A6—prostate cancer	0.00027	0.00832	CbGpPWpGaD
Deferasirox—CYP3A4—Tamoxifen metabolism—CYP2C19—prostate cancer	0.000269	0.00829	CbGpPWpGaD
Deferasirox—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP3A43—prostate cancer	0.000266	0.00823	CbGpPWpGaD
Deferasirox—CYP3A4—Oxidation by Cytochrome P450—CYP3A43—prostate cancer	0.000263	0.00812	CbGpPWpGaD
Deferasirox—CYP3A4—Metapathway biotransformation—GSTCD—prostate cancer	0.00026	0.00803	CbGpPWpGaD
Deferasirox—CYP3A4—Metapathway biotransformation—GSTK1—prostate cancer	0.00026	0.00803	CbGpPWpGaD
Deferasirox—CYP3A4—Tamoxifen metabolism—CYP2A6—prostate cancer	0.000259	0.008	CbGpPWpGaD
Deferasirox—CYP3A4—Tryptophan metabolism—CYP7B1—prostate cancer	0.000256	0.00791	CbGpPWpGaD
Deferasirox—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—prostate cancer	0.000253	0.00781	CbGpPWpGaD
Deferasirox—CYP3A4—Constitutive Androstane Receptor Pathway—SULT1A1—prostate cancer	0.00025	0.00772	CbGpPWpGaD
Deferasirox—CYP3A4—Estrogen metabolism—NQO1—prostate cancer	0.000247	0.00761	CbGpPWpGaD
Deferasirox—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—prostate cancer	0.000238	0.00735	CbGpPWpGaD
Deferasirox—CYP3A4—Estrogen metabolism—CYP1B1—prostate cancer	0.000236	0.0073	CbGpPWpGaD
Deferasirox—CYP3A4—Xenobiotics—CYP2E1—prostate cancer	0.000229	0.00707	CbGpPWpGaD
Deferasirox—CYP3A4—Tamoxifen metabolism—CYP2E1—prostate cancer	0.00022	0.0068	CbGpPWpGaD
Deferasirox—CYP3A4—Aflatoxin activation and detoxification—GGT1—prostate cancer	0.000219	0.00677	CbGpPWpGaD
Deferasirox—CYP3A4—Phase 1 - Functionalization of compounds—CYP3A43—prostate cancer	0.000216	0.00667	CbGpPWpGaD
Deferasirox—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—prostate cancer	0.000215	0.00664	CbGpPWpGaD
Deferasirox—CYP3A4—Tamoxifen metabolism—CYP1B1—prostate cancer	0.000209	0.00645	CbGpPWpGaD
Deferasirox—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP7B1—prostate cancer	0.000207	0.0064	CbGpPWpGaD
Deferasirox—CYP3A4—Estrogen metabolism—COMT—prostate cancer	0.000207	0.00638	CbGpPWpGaD
Deferasirox—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—prostate cancer	0.000205	0.00634	CbGpPWpGaD
Deferasirox—CYP3A4—Oxidation by Cytochrome P450—CYP7B1—prostate cancer	0.000205	0.00631	CbGpPWpGaD
Deferasirox—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—prostate cancer	0.000203	0.00628	CbGpPWpGaD
Deferasirox—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—prostate cancer	0.000197	0.00608	CbGpPWpGaD
Deferasirox—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C19—prostate cancer	0.000192	0.00592	CbGpPWpGaD
Deferasirox—CYP3A4—Estrogen metabolism—GSTM1—prostate cancer	0.000189	0.00583	CbGpPWpGaD
Deferasirox—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—prostate cancer	0.000185	0.00571	CbGpPWpGaD
Deferasirox—CYP3A4—Estrogen metabolism—CYP1A1—prostate cancer	0.000179	0.00553	CbGpPWpGaD
Deferasirox—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP3A5—prostate cancer	0.000178	0.00549	CbGpPWpGaD
Deferasirox—CYP3A4—Oxidation by Cytochrome P450—CYP3A5—prostate cancer	0.000175	0.00542	CbGpPWpGaD
Deferasirox—CYP3A4—Tryptophan metabolism—CYP2C18—prostate cancer	0.000173	0.00535	CbGpPWpGaD
Deferasirox—CYP3A4—Irinotecan Pathway—APC—prostate cancer	0.000172	0.0053	CbGpPWpGaD
Deferasirox—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA2—prostate cancer	0.000169	0.00521	CbGpPWpGaD
Deferasirox—CYP3A4—Phase 1 - Functionalization of compounds—CYP7B1—prostate cancer	0.000168	0.00519	CbGpPWpGaD
Deferasirox—CYP3A4—Xenobiotics—CYP1A1—prostate cancer	0.000165	0.00508	CbGpPWpGaD
Deferasirox—CYP3A4—Tamoxifen metabolism—CYP1A1—prostate cancer	0.000158	0.00489	CbGpPWpGaD
Deferasirox—CYP3A4—Cytochrome P450 - arranged by substrate type—TBXAS1—prostate cancer	0.000157	0.00485	CbGpPWpGaD
Deferasirox—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—prostate cancer	0.00015	0.00463	CbGpPWpGaD
Deferasirox—CYP3A4—Phase 1 - Functionalization of compounds—CYP3A5—prostate cancer	0.000144	0.00445	CbGpPWpGaD
Deferasirox—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA1—prostate cancer	0.000142	0.00439	CbGpPWpGaD
Deferasirox—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—prostate cancer	0.00014	0.00432	CbGpPWpGaD
Deferasirox—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—prostate cancer	0.000138	0.00427	CbGpPWpGaD
Deferasirox—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—prostate cancer	0.000135	0.00418	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—UGT2B15—prostate cancer	0.000129	0.00397	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—UGT2B17—prostate cancer	0.000129	0.00397	CbGpPWpGaD
Deferasirox—CYP3A4—Phase 1 - Functionalization of compounds—TBXAS1—prostate cancer	0.000127	0.00393	CbGpPWpGaD
Deferasirox—CYP3A4—Metapathway biotransformation—UGT2B17—prostate cancer	0.000127	0.00392	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—GSTM3—prostate cancer	0.000121	0.00374	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—SULT2B1—prostate cancer	0.000121	0.00374	CbGpPWpGaD
Deferasirox—CYP3A4—Metapathway biotransformation—SULT2B1—prostate cancer	0.000119	0.00369	CbGpPWpGaD
Deferasirox—CYP3A4—Metapathway biotransformation—GSTM3—prostate cancer	0.000119	0.00369	CbGpPWpGaD
Deferasirox—CYP3A4—Tryptophan metabolism—CYP2E1—prostate cancer	0.000118	0.00363	CbGpPWpGaD
Deferasirox—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—prostate cancer	0.000117	0.00361	CbGpPWpGaD
Deferasirox—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—prostate cancer	0.000116	0.00358	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—CYP3A43—prostate cancer	0.000115	0.00354	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—NAT1—prostate cancer	0.000115	0.00354	CbGpPWpGaD
Deferasirox—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—prostate cancer	0.000114	0.00353	CbGpPWpGaD
Deferasirox—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—prostate cancer	0.000113	0.0035	CbGpPWpGaD
Deferasirox—CYP3A4—Metapathway biotransformation—CYP3A43—prostate cancer	0.000113	0.00349	CbGpPWpGaD
Deferasirox—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—prostate cancer	0.000112	0.00346	CbGpPWpGaD
Deferasirox—CYP3A4—Tryptophan metabolism—CYP1B1—prostate cancer	0.000112	0.00344	CbGpPWpGaD
Deferasirox—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—prostate cancer	0.00011	0.00341	CbGpPWpGaD
Deferasirox—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—prostate cancer	0.000107	0.00331	CbGpPWpGaD
Deferasirox—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—prostate cancer	0.000106	0.00327	CbGpPWpGaD
Deferasirox—CYP3A4—Tryptophan metabolism—CYP19A1—prostate cancer	0.000105	0.00324	CbGpPWpGaD
Deferasirox—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA2—prostate cancer	0.000102	0.00315	CbGpPWpGaD
Deferasirox—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—prostate cancer	9.85e-05	0.00304	CbGpPWpGaD
Deferasirox—CYP3A4—Metapathway biotransformation—EPHX1—prostate cancer	9.62e-05	0.00297	CbGpPWpGaD
Deferasirox—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—prostate cancer	9.52e-05	0.00294	CbGpPWpGaD
Deferasirox—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—prostate cancer	9.4e-05	0.0029	CbGpPWpGaD
Deferasirox—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—prostate cancer	9.39e-05	0.0029	CbGpPWpGaD
Deferasirox—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—prostate cancer	9.07e-05	0.0028	CbGpPWpGaD
Deferasirox—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—prostate cancer	9.02e-05	0.00278	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—CYP7B1—prostate cancer	8.92e-05	0.00276	CbGpPWpGaD
Deferasirox—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—prostate cancer	8.9e-05	0.00275	CbGpPWpGaD
Deferasirox—CYP3A4—Metapathway biotransformation—CYP7B1—prostate cancer	8.8e-05	0.00272	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—SULT1E1—prostate cancer	8.7e-05	0.00268	CbGpPWpGaD
Deferasirox—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—prostate cancer	8.69e-05	0.00268	CbGpPWpGaD
Deferasirox—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA1—prostate cancer	8.61e-05	0.00266	CbGpPWpGaD
Deferasirox—CYP3A4—Metapathway biotransformation—SULT1E1—prostate cancer	8.58e-05	0.00265	CbGpPWpGaD
Deferasirox—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—prostate cancer	8.48e-05	0.00262	CbGpPWpGaD
Deferasirox—CYP3A4—Tryptophan metabolism—CYP1A1—prostate cancer	8.46e-05	0.00261	CbGpPWpGaD
Deferasirox—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—prostate cancer	8.37e-05	0.00258	CbGpPWpGaD
Deferasirox—CYP3A4—Phase 1 - Functionalization of compounds—NCOA2—prostate cancer	8.28e-05	0.00256	CbGpPWpGaD
Deferasirox—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—prostate cancer	8.19e-05	0.00253	CbGpPWpGaD
Deferasirox—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—prostate cancer	7.71e-05	0.00238	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—CYP3A5—prostate cancer	7.66e-05	0.00236	CbGpPWpGaD
Deferasirox—CYP3A4—Metapathway biotransformation—CYP3A5—prostate cancer	7.55e-05	0.00233	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—GSTA3—prostate cancer	7.39e-05	0.00228	CbGpPWpGaD
Deferasirox—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—prostate cancer	7.31e-05	0.00226	CbGpPWpGaD
Deferasirox—CYP3A4—Metapathway biotransformation—GSTA3—prostate cancer	7.29e-05	0.00225	CbGpPWpGaD
Deferasirox—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—prostate cancer	6.98e-05	0.00215	CbGpPWpGaD
Deferasirox—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—prostate cancer	6.88e-05	0.00212	CbGpPWpGaD
Deferasirox—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—prostate cancer	6.84e-05	0.00211	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—GSTA4—prostate cancer	6.76e-05	0.00209	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—TBXAS1—prostate cancer	6.76e-05	0.00209	CbGpPWpGaD
Deferasirox—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—prostate cancer	6.75e-05	0.00208	CbGpPWpGaD
Deferasirox—CYP3A4—Metapathway biotransformation—GSTA4—prostate cancer	6.67e-05	0.00206	CbGpPWpGaD
Deferasirox—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—prostate cancer	6.64e-05	0.00205	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—GSTA2—prostate cancer	6.59e-05	0.00203	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—SULT1A1—prostate cancer	6.51e-05	0.00201	CbGpPWpGaD
Deferasirox—CYP3A4—Metapathway biotransformation—SULT1A1—prostate cancer	6.42e-05	0.00198	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—GSTA1—prostate cancer	6.36e-05	0.00196	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—GSTO1—prostate cancer	6.29e-05	0.00194	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—NAT2—prostate cancer	6.29e-05	0.00194	CbGpPWpGaD
Deferasirox—CYP3A4—Metapathway biotransformation—GSTO1—prostate cancer	6.2e-05	0.00191	CbGpPWpGaD
Deferasirox—CYP3A4—Metapathway biotransformation—NAT2—prostate cancer	6.2e-05	0.00191	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—CYP2C18—prostate cancer	6.03e-05	0.00186	CbGpPWpGaD
Deferasirox—CYP3A4—Metapathway biotransformation—CYP2C18—prostate cancer	5.95e-05	0.00184	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—SULT2A1—prostate cancer	5.6e-05	0.00173	CbGpPWpGaD
Deferasirox—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—prostate cancer	5.54e-05	0.00171	CbGpPWpGaD
Deferasirox—CYP3A4—Metapathway biotransformation—SULT2A1—prostate cancer	5.53e-05	0.00171	CbGpPWpGaD
Deferasirox—CYP3A4—Metapathway biotransformation—GPX3—prostate cancer	5.27e-05	0.00163	CbGpPWpGaD
Deferasirox—CYP3A4—Tryptophan metabolism—MDM2—prostate cancer	5.22e-05	0.00161	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—HPGDS—prostate cancer	5.03e-05	0.00155	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—CYP2C19—prostate cancer	4.99e-05	0.00154	CbGpPWpGaD
Deferasirox—CYP3A4—Metapathway biotransformation—CYP2C19—prostate cancer	4.93e-05	0.00152	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—GSTT1—prostate cancer	4.88e-05	0.00151	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—CYP2A6—prostate cancer	4.82e-05	0.00149	CbGpPWpGaD
Deferasirox—CYP3A4—Metapathway biotransformation—AKR1C3—prostate cancer	4.62e-05	0.00143	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—CYP17A1—prostate cancer	4.61e-05	0.00142	CbGpPWpGaD
Deferasirox—CYP3A4—Metapathway biotransformation—CYP17A1—prostate cancer	4.55e-05	0.00141	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—NCOA2—prostate cancer	4.4e-05	0.00136	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—CYP2E1—prostate cancer	4.1e-05	0.00127	CbGpPWpGaD
Deferasirox—CYP3A4—Metapathway biotransformation—CYP2E1—prostate cancer	4.04e-05	0.00125	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—CYP1B1—prostate cancer	3.88e-05	0.0012	CbGpPWpGaD
Deferasirox—CYP3A4—Metapathway biotransformation—CYP1B1—prostate cancer	3.83e-05	0.00118	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—GGT1—prostate cancer	3.76e-05	0.00116	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—NCOA1—prostate cancer	3.71e-05	0.00114	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—CYP19A1—prostate cancer	3.65e-05	0.00113	CbGpPWpGaD
Deferasirox—CYP3A4—Metapathway biotransformation—CYP19A1—prostate cancer	3.6e-05	0.00111	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—RXRA—prostate cancer	3.52e-05	0.00109	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—COMT—prostate cancer	3.4e-05	0.00105	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—GSTP1—prostate cancer	3.38e-05	0.00104	CbGpPWpGaD
Deferasirox—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	3.35e-05	0.00103	CbGpPWpGaD
Deferasirox—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	3.33e-05	0.00103	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—GSTM1—prostate cancer	3.11e-05	0.000959	CbGpPWpGaD
Deferasirox—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	3.06e-05	0.000946	CbGpPWpGaD
Deferasirox—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	2.94e-05	0.000909	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—HAO1—prostate cancer	2.91e-05	0.000897	CbGpPWpGaD
Deferasirox—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	2.9e-05	0.000896	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—TST—prostate cancer	2.37e-05	0.000731	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—GRHL1—prostate cancer	2.37e-05	0.000731	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—PSAT1—prostate cancer	2.37e-05	0.000731	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—CSAD—prostate cancer	2.37e-05	0.000731	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—CBR1—prostate cancer	2.37e-05	0.000731	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—ADI1—prostate cancer	2.37e-05	0.000731	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—CKMT2—prostate cancer	2.2e-05	0.00068	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—UGT2B15—prostate cancer	2.2e-05	0.00068	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—UGT2B17—prostate cancer	2.2e-05	0.00068	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—GRHPR—prostate cancer	2.2e-05	0.00068	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—MBTPS1—prostate cancer	2.07e-05	0.000639	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—PGAM2—prostate cancer	2.07e-05	0.000639	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—GSTM3—prostate cancer	2.07e-05	0.000639	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—AOX1—prostate cancer	2.07e-05	0.000639	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—RFK—prostate cancer	2.07e-05	0.000639	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—SULT2B1—prostate cancer	2.07e-05	0.000639	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—NAGLU—prostate cancer	2.07e-05	0.000639	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—CYP3A43—prostate cancer	1.96e-05	0.000606	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—AMACR—prostate cancer	1.96e-05	0.000606	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—SRD5A2—prostate cancer	1.96e-05	0.000606	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—DEGS1—prostate cancer	1.96e-05	0.000606	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—NAT1—prostate cancer	1.96e-05	0.000606	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—HSD17B1—prostate cancer	1.87e-05	0.000578	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—HPGD—prostate cancer	1.67e-05	0.000515	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—B4GALT4—prostate cancer	1.67e-05	0.000515	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—TNFRSF21—prostate cancer	1.57e-05	0.000484	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—CYP7B1—prostate cancer	1.53e-05	0.000471	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—MTAP—prostate cancer	1.53e-05	0.000471	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—SULT1E1—prostate cancer	1.49e-05	0.000459	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—SRD5A1—prostate cancer	1.49e-05	0.000459	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—HSD17B3—prostate cancer	1.42e-05	0.000438	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—ACSL4—prostate cancer	1.42e-05	0.000438	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—PHGDH—prostate cancer	1.36e-05	0.00042	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—UMPS—prostate cancer	1.36e-05	0.00042	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—ARG2—prostate cancer	1.36e-05	0.00042	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—LDHB—prostate cancer	1.33e-05	0.000412	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—CYP3A5—prostate cancer	1.31e-05	0.000404	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—TCN2—prostate cancer	1.26e-05	0.00039	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—PDHA1—prostate cancer	1.26e-05	0.00039	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—UCP3—prostate cancer	1.26e-05	0.00039	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—GSTA3—prostate cancer	1.26e-05	0.00039	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—SLC22A3—prostate cancer	1.21e-05	0.000372	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—HSD3B1—prostate cancer	1.21e-05	0.000372	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—TBXAS1—prostate cancer	1.16e-05	0.000357	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—GSTA4—prostate cancer	1.16e-05	0.000357	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—GSTA2—prostate cancer	1.13e-05	0.000348	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—ABCG5—prostate cancer	1.11e-05	0.000344	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—SULT1A1—prostate cancer	1.11e-05	0.000344	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—GSTA1—prostate cancer	1.09e-05	0.000336	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—NAT2—prostate cancer	1.08e-05	0.000332	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—HSD3B2—prostate cancer	1.08e-05	0.000332	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—GSTO1—prostate cancer	1.08e-05	0.000332	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—PLCB2—prostate cancer	1.03e-05	0.000318	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—LRP2—prostate cancer	1.03e-05	0.000318	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—CYP2C18—prostate cancer	1.03e-05	0.000318	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—P4HB—prostate cancer	1.01e-05	0.000312	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—SLC22A1—prostate cancer	9.83e-06	0.000304	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—SULT2A1—prostate cancer	9.58e-06	0.000296	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—MED12—prostate cancer	9.43e-06	0.000291	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—GNG5—prostate cancer	9.35e-06	0.000289	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—NCOA3—prostate cancer	9.01e-06	0.000278	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—HPGDS—prostate cancer	8.6e-06	0.000265	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—CYP2C19—prostate cancer	8.54e-06	0.000264	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—GSTT1—prostate cancer	8.34e-06	0.000257	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—ACHE—prostate cancer	8.34e-06	0.000257	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—CYP2A6—prostate cancer	8.24e-06	0.000254	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—AKR1C3—prostate cancer	8.02e-06	0.000248	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—PRKACB—prostate cancer	7.97e-06	0.000246	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—CYP17A1—prostate cancer	7.89e-06	0.000244	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—NCOA2—prostate cancer	7.52e-06	0.000232	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—SLC5A5—prostate cancer	7.17e-06	0.000221	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—CYP2E1—prostate cancer	7.01e-06	0.000216	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—NQO1—prostate cancer	6.93e-06	0.000214	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—TH—prostate cancer	6.83e-06	0.000211	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—CYP1B1—prostate cancer	6.64e-06	0.000205	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—GGT1—prostate cancer	6.43e-06	0.000199	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—NCOA1—prostate cancer	6.34e-06	0.000196	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—CYP19A1—prostate cancer	6.25e-06	0.000193	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—RXRA—prostate cancer	6.03e-06	0.000186	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—COMT—prostate cancer	5.81e-06	0.000179	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—GSTP1—prostate cancer	5.78e-06	0.000178	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—ITPR1—prostate cancer	5.69e-06	0.000176	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—TYMS—prostate cancer	5.37e-06	0.000166	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—GSTM1—prostate cancer	5.31e-06	0.000164	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—LPL—prostate cancer	5.21e-06	0.000161	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—CYP1A1—prostate cancer	5.03e-06	0.000155	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—ERCC2—prostate cancer	4.99e-06	0.000154	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—MTHFR—prostate cancer	4.69e-06	0.000145	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—PPARA—prostate cancer	4.6e-06	0.000142	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—CAV1—prostate cancer	4.33e-06	0.000134	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—PIK3CG—prostate cancer	3.94e-06	0.000122	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—INS—prostate cancer	3.73e-06	0.000115	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—CREBBP—prostate cancer	3.66e-06	0.000113	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—PIK3CD—prostate cancer	3.47e-06	0.000107	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—NOS3—prostate cancer	3.27e-06	0.000101	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—PIK3CB—prostate cancer	3.02e-06	9.33e-05	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—PTGS2—prostate cancer	2.99e-06	9.24e-05	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—PTEN—prostate cancer	2.61e-06	8.06e-05	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—EP300—prostate cancer	2.49e-06	7.69e-05	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.84e-06	5.69e-05	CbGpPWpGaD
Deferasirox—CYP3A4—Metabolism—AKT1—prostate cancer	1.5e-06	4.65e-05	CbGpPWpGaD
